Citadel Advisors
IMA

Citadel Advisors’s ImageneBio Inc IMA Stock Holding History

Citadel Advisors’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$622K Buy
124,345
+37,867
+44% +$246K ﹤0.01% 8761
2025
Q4 		$597K Sell
86,478
-35,769
-29% -$265K ﹤0.01% 8606
2025
Q3 		$996K Buy
122,247
+109,062
+827% +$1.45M ﹤0.01% 7539
2025
Q2 		$212K Buy
13,185
+6,544
+99% +$96.1K ﹤0.01% 10552
2025
Q1 		$102K Sell
6,641
-56
-0.8% -$966 ﹤0.01% 11427
2024
Q4 		$132K Sell
6,697
-7,054
-51% -$143K ﹤0.01% 11076
2024
Q3 		$285K Sell
13,751
-6,640
-33% -$134K ﹤0.01% 9438
2024
Q2 		$404K Buy
20,391
+7,140
+54% +$126K ﹤0.01% 8497
2024
Q1 		$226K Sell
13,251
-1,597
-11% -$29.1K ﹤0.01% 10078
2023
Q4 		$351K Sell
14,848
-2,380
-14% -$77.6K ﹤0.01% 8829
2023
Q3 		$895K Buy
17,228
+14,051
+442% +$846K ﹤0.01% 6816
2023
Q2 		$250K Sell
3,177
-11,831
-79% -$848K ﹤0.01% 9406
2023
Q1 		$621K Sell
15,008
-164,587
-92% -$7.56M ﹤0.01% 7860
2022
Q4 		$5.73M Sell
179,595
-278
-0.2% -$8.88K ﹤0.01% 3628
2022
Q3 		$7.66M Buy
179,873
+2,673
+2% +$155K ﹤0.01% 3156
2022
Q2 		$9.42M Sell
177,200
-75
-0% -$4.14K ﹤0.01% 2765
2022
Q1 		$13M Sell
177,275
-71
-0% -$7.55K ﹤0.01% 2558
2021
Q4 		$26.7M Buy
177,346
+89
+0.1% +$14.4K 0.01% 1715
2021
Q3 		$26.8M Sell
177,257
-2,461
-1% -$358K 0.01% 1669
2021
Q2 		$29.5M Buy
179,718
+8,629
+5% +$1.9M 0.01% 1632
2021
Q1 		$58M Buy
+171,089
New +$58.6M 0.01% 933

Other funds holding IMA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors's IMA Position: Q1 2026 in Review

Citadel Advisors increased its ImageneBio Inc (IMA) stake by 44% in Q1 2026, buying an estimated $246K and bringing the position to 124,345 shares worth $622K. The position accounts for ﹤0.01% of the portfolio, ranked #8761.

Citadel Advisors first reported a position in IMA in Q1 2021 and has held it in 21 quarters since. The position peaked at $58M in Q1 2021. 39 funds tracked by Wall St. Rank hold IMA as of Q1 2026.

  • Citadel Advisors held 124,345 shares of ImageneBio Inc worth $622K as of Q1 2026.
  • Citadel Advisors bought 37,867 ImageneBio Inc shares in Q1 2026, an estimated $246K.
  • ImageneBio Inc made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #8761 holding.
  • Citadel Advisors first reported a position in ImageneBio Inc in Q1 2021 and has held it in 21 quarters since.
  • Citadel Advisors's ImageneBio Inc position peaked at $58M in Q1 2021.
  • 39 funds tracked by Wall St. Rank held ImageneBio Inc as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.